AI Verdict
BSX has stronger fundamentals based on our AI analysis.
BSX vs HCA Fundamental Comparison
| Metric | BSX | HCA |
|---|---|---|
| Revenue | $20.1B | $75.6B |
| Net Income | $2.9B | $6.8B |
| Net Margin | 14.4% | 9.0% |
| ROE | 12.0% | N/A |
| ROA | 6.6% | 11.2% |
| Current Ratio | 1.62x | 0.97x |
| Debt/Equity | 0.46x | N/A |
| EPS | $1.94 | $28.33 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs HCA: Frequently Asked Questions
Is BSX or HCA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), BSX has stronger fundamentals. BSX is rated BUY (80% confidence) while HCA is rated BUY (75% confidence). This is not investment advice.
How does BSX compare to HCA fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 12.0% vs HCA Healthcare, Inc.'s N/A. Net margins are 14.4% vs 9.0% respectively.
Which stock pays higher dividends, BSX or HCA?
BSX has a dividend yield of N/A or no dividend while HCA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or HCA for long term?
For long-term investing, consider that BSX has BUY rating with 80% confidence, while HCA has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs HCA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs HCA, the AI consensus favors BSX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.